Identification of Early Markers of Response and Resistance to Trastuzumab
Clinical trial NCT01834950 · COMPLETED
Trial details
- NCT number
- NCT01834950
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2013-03-27
- Primary completion
- 2017-12-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.